Department of Psychiatry, National Clinical Research Center for Mental Disorders, and National Center for Mental Disorders, The Second Xiangya Hospital of Central South University, Changsha, 410011, Hunan, China.
Department of Psychiatry, Qiqihar Medical University, Qiqihar, 161006, Heilongjiang, China.
BMC Psychiatry. 2023 Nov 7;23(1):809. doi: 10.1186/s12888-023-05305-7.
Anomalies in regional homogeneity (ReHo) have been documented in patients with major depressive disorder (MDD) and sleep disturbances (SDs). This investigation aimed to scrutinize changes in ReHo in MDD patients with comorbid SD, and to devise potential diagnostic biomarkers for detecting sleep-related conditions in patients with MDD.
Patients with MDD and healthy controls underwent resting-state functional magnetic resonance imaging scans. SD severity was quantified using the 17-item Hamilton Rating Scale for Depression. Subsequent to the acquisition of imaging data, ReHo analysis was performed, and a support vector machine (SVM) method was employed to assess the utility of ReHo in discriminating MDD patients with SD.
Compared with MDD patients without SD, MDD patients with SD exhibited increased ReHo values in the right posterior cingulate cortex (PCC)/precuneus, right median cingulate cortex, left postcentral gyrus (postCG), and right inferior temporal gyrus (ITG). Furthermore, the ReHo values in the right PCC/precuneus and ITG displayed a positive correlation with clinical symptoms across all patients. SVM classification results showed that a combination of abnormal ReHo in the left postCG and right ITG achieved an overall accuracy of 84.21%, a sensitivity of 81.82%, and a specificity of 87.50% in identifying MDD patients with SD from those without SD.
We identified disrupted ReHo patterns in MDD patients with SD, and presented a prospective neuroimaging-based diagnostic biomarker for these patients.
患有重度抑郁症(MDD)和睡眠障碍(SD)的患者存在局部一致性(ReHo)异常。本研究旨在探讨 MDD 伴 SD 患者 ReHo 的变化,并为检测 MDD 患者睡眠相关情况设计潜在的诊断生物标志物。
MDD 患者和健康对照组接受静息态功能磁共振成像扫描。SD 严重程度使用 17 项汉密尔顿抑郁评定量表进行量化。在获得图像数据后,进行 ReHo 分析,并使用支持向量机(SVM)方法评估 ReHo 在区分 MDD 伴 SD 患者中的效用。
与无 SD 的 MDD 患者相比,MDD 伴 SD 的患者右侧后扣带回皮层(PCC)/楔前叶、右侧中央扣带回、左侧后中央回(postCG)和右侧颞下回(ITG)的 ReHo 值增加。此外,所有患者的右侧 PCC/楔前叶和 ITG 的 ReHo 值与临床症状呈正相关。SVM 分类结果显示,左侧 postCG 和右侧 ITG 异常 ReHo 的组合在识别 MDD 伴 SD 患者与无 SD 患者时,总体准确率为 84.21%,敏感度为 81.82%,特异性为 87.50%。
我们发现 MDD 伴 SD 患者的 ReHo 模式存在紊乱,并提出了一种基于神经影像学的前瞻性诊断生物标志物。